Robust CRO Market Is Driving New Merger and Acquisition Activity

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-12-02-2004
Volume 28
Issue 11

The blockage in the new product pipeline may be breaking. CROs report increased demand for late-stage development services in their latest round of earnings reports.

External Link - article-137411.pdf

Articles in this issue
Acceptable Analytical Practices for Dissolution Testing of Poorly Soluble Compounds
The Preparation and Evaluation of Albendazole Microspheres for Colonic Delivery
In the Spotlight-December 2004
In Between the Light and the Dark: Developments in Photosensitive Pharmaceuticals
Safety Problems Roil Pharma and FDA
December 2004
Robust CRO Market Is Driving New Merger and Acquisition Activity
The Seventh Annual International Employment Survey
Pharmaco-Fakery
Recent Videos
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Jens Schmidt, associate director MSAT at Lonza
Roger Viney, PhD, chief commercial officer for ICE Pharma
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Related Content
Young female tech or scientist performs protein assay | Image Credit: © tilialucida - stock.adobe.com

Leaving STEM Skills on the Table

Susan Haigney
February 13th 2025
Article

Investing in STEM programs for girls in an education setting and then supporting women as they excel in their professional careers is key to ensuring that vital highly skilled personnel are not left behind.

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Felicity Thomas
July 11th 2023
Podcast

In this episode, Sergey Vlasenko from Agilent chats about bio/pharmaceutical manufacturing trends, with a particular focus on oligonucleotides.

Group of participants engaging in interactive business seminar, with one individual raising hand while seated and another person presenting in background with laptop | Image Credit: © Seventyfour - stock.adobe.com

Split Opinions on Training Strategies

Patrick Lavery
February 9th 2025
Article

Survey results show that being intellectually stimulated and getting assigned challenging projects are two key drivers of employee satisfaction, yet job training is lacking.

Drug Solutions Podcast: Examining the State of Biopharma Investment

Drug Solutions Podcast: Examining the State of Biopharma Investment

Grant Playter
June 6th 2023
Podcast

In this episode, Siegfried Schmitt, vice president, Technical at Parexel, discusses the state of biopharma investment in 2023.

Movement towards the intended goal. Moving forward, step by step. Labor and aspiration. Motivation, self-development. Business strategic planning, risk management. New opportunities. Achieve. | Image Credit: ©Andrii Yalanskyi – Stock.Adobe.com

Steps to Process Development Optimization

Susan Haigney
February 4th 2025
Article

The optimization of processes for the development and manufacture of biopharmaceuticals is pivotal for producing quality products.

3d rendering of Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells | Image Credit: © Love Employee - © Love Employee- stock.adobe.com

Advancing ADCs to the Next Level

Feliza Mirasol
February 4th 2025
Article

CDMOs who have integrated technologies can help further the advancement of ADC development.